clinical trials

New research promises to take the guesswork out of matching individual cancer cases to the most effective choices of chemotherapy.

A pioneering public/private consortium is poised to turn the marathon of drug discovery into a team relay, maybe even a short one.

Pharmaceutical companies will increasingly apply the predictive modeling of quantitative pharmacology to do more efficient drug development, says Kathy Giacomini, PhD, co-chair of the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department of the UCSF Schools of Pharmacy and...